Genilume is a preclinical-stage therapeutics company using generative AI and systems biology to design innovative precision medicines and restorative therapies.
Genilume was founded to address a gap in the development of treatments for complex, chronic, age-related illnesses. Uniting shared passions for healthcare and innovation with a commitment to excellence, Genilume was built on a foundation of strong core values and a vision for a new era of healthcare.